Unique ID issued by UMIN | UMIN000015025 |
---|---|
Receipt number | R000017482 |
Scientific Title | A Randomized, Double-blind, Placebo-controlled Study on the Anti-Glycation Effect of Food Containing Pomegranate Extract |
Date of disclosure of the study information | 2014/09/03 |
Last modified on | 2016/04/04 10:33:42 |
A Randomized, Double-blind, Placebo-controlled Study on the Anti-Glycation Effect of Food Containing Pomegranate Extract
Anti-Glycation Effect of Food Containing Pomegranate Extract
A Randomized, Double-blind, Placebo-controlled Study on the Anti-Glycation Effect of Food Containing Pomegranate Extract
Anti-Glycation Effect of Food Containing Pomegranate Extract
Japan |
No (Subjects with high amount of skin AGEs accumulation)
Adult |
Others
NO
To examine the anti-glycation effect of food containing pomegranate extract on blood and skin
Efficacy
HbA1c
Glycoalbumin
(carboxymethyl)lysine (CML)
3-Deoxyglucosone
Pentosidine
Skin AGEs
Skin elasticity
Color difference of skin
Analysis of stains, wrinkles, pores, skin color, hidden stains using VISIA
Horny layer AGEs
Fasting Plasma Glucose
Insulin
Anti-aging QOL common questionnaire test
Interventional
Parallel
Randomized
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Capsule containing 100mg of pomegranate extract, 1 per serving per day
Capsule not containing pomegranate extract, 1 per serving per day
50 | years-old | <= |
65 | years-old | >= |
Female
(1)(Healthy) post-menopausal females aged 50 to 65 years old.
(2)Subjects whose skin AGEs accumulation determined by AGEReader is more than 2.0.
(3)Subjects who prefer carbohydrates or sweets.
(4)Subjects whose waist circumference is more than 90 cm.
(5)Subjects giving written informed consent.
(1)Subjects who use oral medication affecting blood sugar.
(2)Subjects who constantly use supplements and/or functional foods affecting blood sugar.
(3)Smoker.
(4)Subjects who have allergic reaction to pomegranate.
(5)Subjects who can't promise not to drink four or more times a week and more than 2 cups in terms of sake in a day.
(6)Subjects who daily average sleep time is less than 6 hours approximately.
(7)Subjects who are during treatment and/or medication with lifestyle-related diseases related to glycation.
(8)Subjects who are suffering from a disease that requires urgent treatment or are having severe complications.
(9)Subjects who have under treatment or a history of drug addiction and/or alcoholism.
(10)Subjects who are planned to participate in other clinical study.
(11)Subjects who are judged as unsuitable for the study by the investigator for other reason.
36
1st name | |
Middle name | |
Last name | Haruhi Sugimura |
C'est la vie Shimbashi Clinic
Medical office
2-39-3 Nishishimbashi, Minato-ku, Tokyo
03-5408-8671
h-sugimura@shinkokai.jp
1st name | |
Middle name | |
Last name | Yoshika Komori |
KSO Corporation
Sales department
1-9-7 Shibaura, Minato-ku, Tokyo
03-3452-7733
yoshi@kso.co.jp
KSO Corporation
Morishita Jintan Co.,Ltd.
Profit organization
Ministry of Agriculture, Forestry and Fisheries
NO
2014 | Year | 09 | Month | 03 | Day |
Unpublished
Completed
2014 | Year | 08 | Month | 25 | Day |
2014 | Year | 08 | Month | 30 | Day |
2014 | Year | 09 | Month | 02 | Day |
2016 | Year | 04 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017482
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |